Clinical Trials Logo
  1. Home
  2. CKD Stage 4
  3. NCT06083545

The Effects of Application Intervention on the Physiological Indicators and Low Protein Diet Cognition Among the Patients With Chronic Kidney Disease

CKD Stage 4 Clinical Trial

Official title:
The Effects of Application Intervention on the Physiological Indicators and Low Protein Diet Cognition Among the Patients With Chronic Kidney Disease

Clinical Trial Summary

The effects of Application intervention on the physiological indicators and low protein diet cognition among the patients with chronic kidney disease

Clinical Trial Description

The low-protein diet app introduces the perceived significant efficacy of low-protein diets for patients with chronic kidney disease. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06083545
Study type Interventional
Source Tri-Service General Hospital
Contact
Status Enrolling by invitation
Phase N/A
Start date July 15, 2023
Completion date July 20, 2025
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03596749 - The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4 Phase 3
Not yet recruiting NCT05514184 - Plant-Focused Nutrition in Patients With Diabetes and Chronic Kidney Disease N/A
Recruiting NCT03415074 - Could Ketoanalogue-supplemented Low Protein Diet Defer Dialysis in Advanced Diabetic Kidney Disease? (K-DDD) N/A
Not yet recruiting NCT04102319 - Serum Hepcidin, Haemoglobin Level and Iron Status in Chronic Kidney Disease Patients (CKD) With Anaemia
Recruiting NCT05309785 - Safety and Efficacy of Canagliflozin in Advanced CKD Phase 4
Not yet recruiting NCT06094920 - Treatment Optimization for Patients With Type 2 Diabetes Using Empagliflozin and Finerenone in a Remote Clinical Trial Phase 4
Completed NCT05705011 - Frailty, Cognitive Function and Health-related Quality of Life in Older Adults With Advanced Chronic Kidney Disease.
Completed NCT03588884 - Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency Phase 4
Recruiting NCT05508009 - Early Trial of Allogeneic Hematopoietic Stem Cell Transplantation for Patients Who Will Receive a Kidney Transplant From the Same Donor Phase 1/Phase 2
Recruiting NCT04633304 - A Single Arm sTudy to Evaluate the Effectiveness of EndoAVF in a Pre-dialysis Population (STEP Study) N/A
Completed NCT04862715 - The Iron and Muscle Study Phase 4